A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Theresa May said she is "ambitious and positive" for a Brexit deal as EU leaders gave the go ahead for preparations for second phase talks.
Merseyside Police have launched an investigation after crowd trouble at Goodison Park - during which a fan appeared to attack a player.
US-backed Syrian forces have declared victory in Raqqa days after it said it had cleared the city of members of so-called Islamic State.